Variant report

Variant	rs7653157
Chromosome Location	chr3:140650178-140650179
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr3:140646965..140650706-chr3:140659494..140663953,5	MCF-7	breast:
2	chr3:140645748..140651447-chr3:140658379..140662815,6	MCF-7	breast:
3	chr3:140641570..140644550-chr3:140649016..140650744,2	K562	blood:

Variant related genes	Relation type
ENSG00000114120	Chromatin interaction

Extended variants
information (count: 16 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:11)

rs_ID	r²[population]
rs1109282	0.87[TSI][hapmap]
rs11720342	0.87[TSI][hapmap]
rs1593625	0.93[EUR][1000 genomes]
rs16850917	0.87[TSI][hapmap]
rs16850921	0.87[TSI][hapmap]
rs16850924	0.87[TSI][hapmap]
rs2292919	0.87[TSI][hapmap]
rs2871615	0.87[TSI][hapmap]
rs36034540	1.00[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs3773835	0.87[TSI][hapmap]
rs3773837	0.87[TSI][hapmap]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv591865	chr3:140396022-140728850	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	11 gene(s)	inside rSNPs	diseases
2	nsv1005522	chr3:140454632-140685915	Weak transcription Active TSS Strong transcription Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
3	nsv536732	chr3:140454632-140685915	Strong transcription Weak transcription Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
4	nsv521218	chr3:140643038-140665147	Active TSS Weak transcription Flanking Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
5	esv3364537	chr3:140646303-140668571	ZNF genes & repeats Flanking Active TSS Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs7653157	SLC25A36	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:28 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:140646800-140650200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
2	chr3:140649000-140650200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr3:140649600-140650400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr3:140649600-140650800	Enhancers	HSMM	muscle
5	chr3:140649600-140651400	Enhancers	Muscle Satellite Cultured Cells	--
6	chr3:140649800-140650200	Active TSS	H1 Cell Line	embryonic stem cell
7	chr3:140649800-140650200	Active TSS	HUES6 Cell Line	embryonic stem cell
8	chr3:140649800-140650200	Active TSS	iPS-20b Cell Line	embryonic stem cell
9	chr3:140649800-140650400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr3:140649800-140650400	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr3:140650000-140650200	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr3:140650000-140650200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr3:140650000-140650200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr3:140650000-140650200	Active TSS	iPS-15b Cell Line	embryonic stem cell
15	chr3:140650000-140650200	Active TSS	iPS-18 Cell Line	embryonic stem cell
16	chr3:140650000-140650200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr3:140650000-140650400	Active TSS	ES-I3 Cell Line	embryonic stem cell
18	chr3:140650000-140650400	Active TSS	H9 Cell Line	embryonic stem cell
19	chr3:140650000-140650400	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr3:140650000-140650400	Active TSS	HUES48 Cell Line	embryonic stem cell
21	chr3:140650000-140650400	Active TSS	HUES64 Cell Line	embryonic stem cell
22	chr3:140650000-140650400	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
23	chr3:140650000-140650400	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr3:140650000-140650400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
25	chr3:140650000-140650400	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
26	chr3:140650000-140650400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr3:140650000-140650600	Enhancers	Osteobl	bone
28	chr3:140650000-140651000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links